⚙

Pathophysiology Nodes

5
5 shared nodes are defined in this module.
◉

Cell Types

4
Pulmonary alveolar type 2 cell CL:0002063 Cell Ontology (CL) Relation: this mechanism module involves this cell type This mechanism module involves Pulmonary alveolar type 2 cell (CL:0002063). CL:0002063 is a cell type from the Cell Ontology. Pulmonary capillary endothelial cell CL:4028001 Cell Ontology (CL) Relation: this mechanism module involves this cell type This mechanism module involves Pulmonary capillary endothelial cell (CL:4028001). CL:4028001 is a cell type from the Cell Ontology. Pulmonary alveolar type 1 cell CL:0002062 Cell Ontology (CL) Relation: this mechanism module involves this cell type This mechanism module involves Pulmonary alveolar type 1 cell (CL:0002062). CL:0002062 is a cell type from the Cell Ontology. Pericyte CL:0000669 Cell Ontology (CL) Relation: this mechanism module involves this cell type This mechanism module involves Pericyte (CL:0000669). CL:0000669 is a cell type from the Cell Ontology.
⇄

Biological Processes

8
Cellular response to reactive oxygen species GO:0034614 ↑ INCREASED Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves increased Cellular response to reactive oxygen species (GO:0034614). GO:0034614 is a biological process from the Gene Ontology. Inflammatory response GO:0006954 ↑ INCREASED Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves increased Inflammatory response (GO:0006954). GO:0006954 is a biological process from the Gene Ontology. Cell-cell junction organization GO:0045216 ↓ DECREASED Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves decreased Cell-cell junction organization (GO:0045216). GO:0045216 is a biological process from the Gene Ontology. Tight junction organization GO:0120193 ↓ DECREASED Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves decreased Tight junction organization (GO:0120193). GO:0120193 is a biological process from the Gene Ontology. Adherens junction organization GO:0034332 ↓ DECREASED Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves decreased Adherens junction organization (GO:0034332). GO:0034332 is a biological process from the Gene Ontology. Positive regulation of vascular permeability GO:0043117 ↑ INCREASED Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves increased Positive regulation of vascular permeability (GO:0043117). GO:0043117 is a biological process from the Gene Ontology. Leukocyte migration GO:0050900 ↑ INCREASED Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves increased Leukocyte migration (GO:0050900). GO:0050900 is a biological process from the Gene Ontology. Respiratory gaseous exchange by respiratory system GO:0007585 ↓ DECREASED Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves decreased Respiratory gaseous exchange by respiratory system (GO:0007585). GO:0007585 is a biological process from the Gene Ontology.
i

Notes

This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "alveolar_capillary_barrier_failure#Alveolar Epithelial and Endothelial Junctional Disruption"). Disorder-specific substitutions at the trigger node: ARDS substitutes a direct pulmonary or indirect systemic insult; high-altitude pulmonary edema substitutes sustained alveolar hypoxia with HIF-1-alpha signaling; influenza and tuberculosis substitute alveolar pathogen replication and the ensuing immune response; COPD substitutes repeated whole cigarette smoke exposure; inhalational injury substitutes an oxidant gas or particulate; and lung transplantation substitutes cold-storage ischemia-reperfusion. The conserved central cell types are the pulmonary alveolar type 1 and type 2 cell and the pulmonary capillary endothelial cell. Much of the direct human evidence for the trans-barrier propagation step comes from microphysiological alveolus-on-chip systems rather than from patients, because separating the epithelial from the endothelial compartment while exposing only one of them is not achievable in vivo. That is a strength for establishing the coupling and a limitation for establishing its magnitude in human disease; conforming entries should keep the evidence_source distinction visible rather than presenting chip results as clinical observations. This module is deliberately narrower than `epithelial_barrier_dysfunction`, which models the allergic / type-2 "epithelial barrier hypothesis" across skin, airway, gut, and esophagus and terminates in IgE sensitization and the atopic march. That module is about allergen penetration driving sensitization; this one is about blood-gas barrier mechanics driving edema and gas-exchange failure. A disorder may legitimately conform to both.
↗

Used By Disorder Entries

2
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence-backed metadata.
Pathograph: causal mechanism network for Alveolar-Capillary Barrier Failure Module Interactive directed graph showing how this shared module's pathophysiology nodes connect.
⚙

Pathophysiology

5
Alveolar-Capillary Interface Insult
trigger
An insult is delivered to the alveolar surface or to the capillary side of the blood-gas barrier. The initiating agents are heterogeneous — oxidant gases, airborne particulates, whole cigarette smoke, replicating pathogens, sustained alveolar hypoxia, and cold-storage ischemia-reperfusion — but each converges on oxidative stress and innate inflammatory signaling at the interface. This node is the disorder-specific entry point; conforming entries substitute their own agent here and inherit the chain below.
Pulmonary alveolar type 2 cell CL:0002063 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Pulmonary alveolar type 2 cell (CL:0002063). CL:0002063 is a cell type from the Cell Ontology. Pulmonary capillary endothelial cell CL:4028001 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Pulmonary capillary endothelial cell (CL:4028001). CL:4028001 is a cell type from the Cell Ontology.
Cellular response to reactive oxygen species GO:0034614 ↑ INCREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased Cellular response to reactive oxygen species (GO:0034614). GO:0034614 is a biological process from the Gene Ontology. Inflammatory response GO:0006954 ↑ INCREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased Inflammatory response (GO:0006954). GO:0006954 is a biological process from the Gene Ontology.
Show evidence (1 reference)
PMID:42546767 SUPPORT In Vitro
"Apical exposure to DPM induced dose-dependent cytotoxicity, increased barrier permeability, elevated reactive oxygen species, and DNA damage in both epithelial and endothelial layers, demonstrating trans-barrier propagation of particulate-induced injury."
Supports a particulate insult at the alveolar surface producing oxidative injury and barrier compromise as the initiating step.
Cyclic Mechanical Strain Amplification
amplifier
Breathing subjects the alveolar wall to continuous cyclic deformation. Within the physiological range this strain maintains barrier and surfactant function, but supraphysiological strain — from mechanical ventilation, hyperinflation, or vigorous spontaneous effort — amplifies an established insult rather than initiating one on its own. Strain increases apparent permeability, potentiates pathogen translocation, and augments profibrotic signaling in the injured alveolar wall. This node is a modifier of severity and is why the same insult produces different barrier outcomes in a spontaneously breathing and a mechanically ventilated lung.
Pulmonary alveolar type 1 cell CL:0002062 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Pulmonary alveolar type 1 cell (CL:0002062). CL:0002062 is a cell type from the Cell Ontology. Pulmonary alveolar type 2 cell CL:0002063 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Pulmonary alveolar type 2 cell (CL:0002063). CL:0002063 is a cell type from the Cell Ontology.
Cell-cell junction organization GO:0045216 ↓ DECREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased Cell-cell junction organization (GO:0045216). GO:0045216 is a biological process from the Gene Ontology.
Show evidence (1 reference)
PMID:41406599 SUPPORT In Vitro
"We demonstrate that cyclic stretching significantly amplifies fibrotic signaling in the presence of transforming growth factor-beta 1 (TGF-β1), evidenced by increased expression of extracellular matrix (ECM) components such as collagen I, collagen III, and fibronectin."
Supports cyclic strain acting as an amplifier of an existing injury signal rather than an independent trigger, since amplification is reported in the presence of TGF-beta 1.
Alveolar Epithelial and Endothelial Junctional Disruption
central effector
Tight and adherens junction complexes are lost on both faces of the barrier — ZO-1 and occludin between alveolar epithelial cells, VE-cadherin and PECAM-1 between capillary endothelial cells — with visible intercellular gap formation, falling transepithelial electrical resistance, and shedding of soluble adhesion molecules into the alveolar and vascular compartments. This is the rate-limiting, disorder-agnostic step: whatever the initiating insult, the barrier fails here, and this is the node conforming disorder entries should target.
Pulmonary alveolar type 1 cell CL:0002062 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Pulmonary alveolar type 1 cell (CL:0002062). CL:0002062 is a cell type from the Cell Ontology. Pulmonary alveolar type 2 cell CL:0002063 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Pulmonary alveolar type 2 cell (CL:0002063). CL:0002063 is a cell type from the Cell Ontology. Pulmonary capillary endothelial cell CL:4028001 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Pulmonary capillary endothelial cell (CL:4028001). CL:4028001 is a cell type from the Cell Ontology.
Tight junction organization GO:0120193 ↓ DECREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased Tight junction organization (GO:0120193). GO:0120193 is a biological process from the Gene Ontology. Adherens junction organization GO:0034332 ↓ DECREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased Adherens junction organization (GO:0034332). GO:0034332 is a biological process from the Gene Ontology.
Cell-cell junction GO:0005911 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves decreased Cell-cell junction (GO:0005911). GO:0005911 is a cellular component from the Gene Ontology.
Show evidence (2 references)
PMID:41477823 SUPPORT In Vitro
"However, we observed areas of cell death aggregation and Mtb replication that progressed to a severe disruption of both the epithelial and endothelial barrier."
Shows a pathogen insult converging on simultaneous epithelial and endothelial barrier disruption, supporting this as the shared central step.
PMID:42204607 SUPPORT In Vitro
"Using this approach, significant barrier disruption and cytotoxicity were observed when MIT was introduced into the alveolar lung-on-chip."
A chemically distinct insult reaching the same barrier-disruption endpoint, supporting the node's disorder-agnostic character.
Trans-Barrier Injury Propagation and Increased Permeability
effector
Permeability of the blood-gas barrier rises, and injury crosses it. Exposure confined to the alveolar epithelial surface produces measurable injury in the capillary endothelium that was never directly exposed, and the reverse coupling holds for insults delivered to the vascular side. Propagation is mediated by soluble mediators, oxidative signaling, and adhesion-molecule shedding acting over short distances across the fused basement membrane rather than by direct contact of the agent with the second layer. The functional consequence is a barrier that passes protein and fluid.
Pulmonary capillary endothelial cell CL:4028001 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Pulmonary capillary endothelial cell (CL:4028001). CL:4028001 is a cell type from the Cell Ontology. Pericyte CL:0000669 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Pericyte (CL:0000669). CL:0000669 is a cell type from the Cell Ontology.
Positive regulation of vascular permeability GO:0043117 ↑ INCREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased Positive regulation of vascular permeability (GO:0043117). GO:0043117 is a biological process from the Gene Ontology. Leukocyte migration GO:0050900 ↑ INCREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased Leukocyte migration (GO:0050900). GO:0050900 is a biological process from the Gene Ontology.
Show evidence (2 references)
PMID:42473541 SUPPORT In Vitro
"This enabled us to establish that repeated WCS exposure of the AEC2 monolayer leads to complete disintegration of the vascularized endothelial networks, a process likely mediated by AEC2 cells as vascular networks remained intact in response to WCS in absence of AEC2."
The AEC2-dependence controls for direct smoke contact and is the strongest available evidence that epithelial injury is transmitted to the endothelium; the authors' own hedge on mediation is preserved.
PMID:42083145 SUPPORT In Vitro
"In alveolar lavage, soluble intercellular adhesion molecule (ICAM)-1, activated leukocyte cell adhesion molecule (ALCAM), and epithelial cell adhesion molecule (EpCAM) were significantly increased after CS-IRI"
Documents compartment-specific adhesion-molecule shedding as a mediator available to carry injury signals across the barrier.
Protein-Rich Alveolar Flooding and Gas-Exchange Failure
consequence
Protein-rich fluid accumulates in the interstitium and airspace. Flooded and collapsed alveoli continue to be perfused but no longer ventilated, producing shunt physiology, hypoxemia, and reduced compliance. Surfactant is diluted and inactivated by the exuded protein, lowering the surface-tension threshold for further collapse and closing a positive-feedback loop back onto the barrier. Whether the process resolves through epithelial repair and active fluid clearance or progresses to fibroproliferative remodeling is determined downstream and is disorder-specific.
Respiratory gaseous exchange by respiratory system GO:0007585 ↓ DECREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased Respiratory gaseous exchange by respiratory system (GO:0007585). GO:0007585 is a biological process from the Gene Ontology.
Show evidence (2 references)
PMID:41786071 SUPPORT Model Organism
"As expected, hypoxia caused an increase in lung water content, lung injury scores, and inflammatory cytokine release, as well as a decrease in blood-gas barrier-related proteins."
Couples loss of blood-gas barrier proteins to measured lung water accumulation in the canine high-altitude model, linking the barrier lesion to the flooding endpoint.
PMID:42083145 SUPPORT In Vitro
"Our findings show that this model reliably recapitulates key elements of IRI pathophysiology observed in the clinical scenario, including edema formation, barrier dysfunction, cytokine release, soluble adhesion molecule expression, and transcriptional reprogramming."
Reports edema formation and barrier dysfunction together as the recapitulated endpoint, supporting flooding as the terminal consequence of the chain.